Pregabalin versus placebo in targeting pro-nociceptive mechanisms to prevent chronic pain after whiplash injury in at-risk individuals - a feasibility study for a randomised controlled trial.
J Nikles, G Keijzers, G Mitchell, S Schug, R Ware, SA McLean, L Connelly, S Gibson, SF Farrell, M Sterling
Trials | Published : 2018
BACKGROUND: Whiplash-associated disorders (WAD) are an enormous and costly burden to Australian society. Up to 50% of people who experience a whiplash injury will never fully recover. Whiplash is resistant to treatment and no early management approach has yet been shown to prevent chronic pain. The early presence of central sensitization is associated with poor recovery. Pregabalin's effects on central sensitization indicate the potential to prevent or modulate these processes after whiplash injury and to improve health outcomes, but this has not been investigated. This paper describes the protocol for a feasibility study for a randomised controlled trial of pregabalin plus evidence-based ad..View full abstract
Awarded by Queensland Emergency Medicine Research Foundation
Awarded by National Health and Medical Research Council
Awarded by Menzies Health Institute Qld